Pavel Sokolovsky

measurable intermediate biological signals

under the microscope · Jan 2026

The power of surrogate endpoints.

“Surrogate endpoints: measurable intermediate biological signals that reliably predict clinical benefit, such as biomarkers or imaging readouts.” By utilizing these proxies, clinical trials can be significantly expedited, decreasing costs and increasing efficiency in drug development. ~ learn more